Sunshine Act Meeting, 20422 [2016-08019]

Download as PDF 20422 Federal Register / Vol. 81, No. 67 / Thursday, April 7, 2016 / Notices Controlled substance Schedule Phenmetrazine (1631) ................................................................................................................................................................................. Amobarbital (2125) ...................................................................................................................................................................................... Pentobarbital (2270) .................................................................................................................................................................................... Secobarbital (2315) ..................................................................................................................................................................................... Glutethimide (2550) ..................................................................................................................................................................................... Nabilone (7379) ........................................................................................................................................................................................... 1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. Phencyclidine (7471) ................................................................................................................................................................................... Phenylacetone (8501) ................................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ Alphaprodine (9010) .................................................................................................................................................................................... Anileridine (9020) ........................................................................................................................................................................................ Etorphine HCI (9059) .................................................................................................................................................................................. Dihydrocodeine (9120) ................................................................................................................................................................................ Diphenoxylate (9170) .................................................................................................................................................................................. Ecgonine (9180) .......................................................................................................................................................................................... Ethylmorphine (9190) .................................................................................................................................................................................. Levomethorphan (9210) .............................................................................................................................................................................. Levorphanol (9220) ..................................................................................................................................................................................... Isomethadone (9226) .................................................................................................................................................................................. Meperidine (9230) ....................................................................................................................................................................................... Meperidine intermediate-A (9232) ............................................................................................................................................................... Meperidine intermediate-B (9233) ............................................................................................................................................................... Meperidine intermediate-C (9234) ............................................................................................................................................................... Metazocine (9240) ....................................................................................................................................................................................... Metopon (9260) ........................................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. Dihydroetorphine (9334) .............................................................................................................................................................................. Levo-alphacetylmethadol (9648) ................................................................................................................................................................. Noroxymorphone (9668) .............................................................................................................................................................................. Phenazocine (9715) .................................................................................................................................................................................... Piminodine (9730) ....................................................................................................................................................................................... Racemethorphan (9732) .............................................................................................................................................................................. Racemorphan (9733) ................................................................................................................................................................................... Alfentanil (9737) .......................................................................................................................................................................................... Remifentanil (9739) ..................................................................................................................................................................................... Sufentanil (9740) ......................................................................................................................................................................................... Carfentanil (9743) ........................................................................................................................................................................................ Tapentadol (9780) ....................................................................................................................................................................................... Bezitramide (9800) ...................................................................................................................................................................................... Moramide-intermediate (9802) .................................................................................................................................................................... mstockstill on DSK4VPTVN1PROD with NOTICES The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: March 29, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–07947 Filed 4–6–16; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 16:35 Apr 06, 2016 Jkt 238001 FOREIGN CLAIMS SETTLEMENT COMMISSION [F.C.S.C. Meeting and Hearing Notice No. 4–16] Sunshine Act Meeting The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR part 503.25) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of open meetings as follows: Thursday, April 14, 2016 10:00 a.m.—Oral hearings on Objection to Commission’s Proposed Decision in Claim No. LIB–III–012. 11:30 a.m.—Issuance of Proposed Decisions in claims against Iraq. Status: Open. All meetings are held at the Foreign Claims Settlement Commission, 600 E Street NW., Washington, DC. Requests for information, or advance notices of intention to observe an open meeting, PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II may be directed to: Patricia M. Hall, Foreign Claims Settlement Commission, 600 E Street NW., Suite 6002, Washington, DC 20579. Telephone: (202) 616–6975. Brian M. Simkin, Chief Counsel. [FR Doc. 2016–08019 Filed 4–5–16; 8:45 am] BILLING CODE 4410–BA–P DEPARTMENT OF JUSTICE [OMB Number 1121–0302] Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: 2016 Supplemental Victimization Survey (SVS) Bureau of Justice Statistics, Department of Justice. ACTION: 30-Day notice. AGENCY: E:\FR\FM\07APN1.SGM 07APN1

Agencies

[Federal Register Volume 81, Number 67 (Thursday, April 7, 2016)]
[Notices]
[Page 20422]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08019]


-----------------------------------------------------------------------

FOREIGN CLAIMS SETTLEMENT COMMISSION

[F.C.S.C. Meeting and Hearing Notice No. 4-16]


Sunshine Act Meeting

    The Foreign Claims Settlement Commission, pursuant to its 
regulations (45 CFR part 503.25) and the Government in the Sunshine Act 
(5 U.S.C. 552b), hereby gives notice in regard to the scheduling of 
open meetings as follows:

Thursday, April 14, 2016

10:00 a.m.--Oral hearings on Objection to Commission's Proposed 
Decision in Claim No. LIB-III-012.

11:30 a.m.--Issuance of Proposed Decisions in claims against Iraq.

    Status: Open.

    All meetings are held at the Foreign Claims Settlement Commission, 
600 E Street NW., Washington, DC. Requests for information, or advance 
notices of intention to observe an open meeting, may be directed to: 
Patricia M. Hall, Foreign Claims Settlement Commission, 600 E Street 
NW., Suite 6002, Washington, DC 20579. Telephone: (202) 616-6975.

Brian M. Simkin,
Chief Counsel.
[FR Doc. 2016-08019 Filed 4-5-16; 8:45 am]
 BILLING CODE 4410-BA-P